Generic Pharmaceuticals Market Revenue 2024 to 2034
Generic Pharmaceuticals Market Revenue 2024 to 2034
The generic pharmaceuticals market was estimated at US$ 392.23 billion in 2023 and is projected to grow to US$ 947.67 billion by 2034, rising at a compound annual growth rate (CAGR) of 8.35% from 2024 to 2034.
Report ID: 10232
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD USD 424.98 Bn
Forecast Year,
USD USD 947.67 Bn
CAGR, 2025 -
8.35%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Generic Pharmaceuticals Market Size Analysis
Generic Pharmaceuticals Market Size By Type 2024 to 2034 (USD )
| Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Simple Generics | 210.57 | 226.78 | 244.58 | 263.32 | 284.39 | 311.78 | 336.67 | 362.30 | 386.35 | 417.39 | 455.88 |
| Biosimilars | 127.90 | 137.96 | 151.32 | 163.71 | 177.40 | 189.73 | 207.77 | 226.44 | 250.40 | 273.14 | 296.18 |
| Specialty Generics | 86.51 | 95.73 | 103.02 | 113.54 | 123.92 | 133.10 | 143.17 | 156.28 | 170.48 | 184.11 | 195.61 |
Generic Pharmaceuticals Market Size By Application 2024 to 2034 (USD )
| Application | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cardiovascular Diseases | 85.07 | 92.20 | 100.40 | 106.28 | 116.08 | 124.12 | 133.44 | 145.16 | 155.12 | 166.11 | 182.08 |
| Cancer | 64.69 | 69.42 | 75.18 | 82.58 | 87.89 | 96.15 | 105.35 | 113.59 | 122.70 | 133.50 | 146.86 |
| Central Nervous System Disorders | 51.50 | 56.09 | 59.70 | 64.84 | 70.76 | 76.45 | 81.72 | 87.25 | 95.98 | 104.02 | 111.65 |
| Respiratory Diseases | 33.46 | 35.76 | 38.11 | 41.81 | 44.57 | 47.73 | 51.65 | 54.82 | 58.59 | 63.51 | 68.02 |
| Hormones & Related Diseases | 30.13 | 33.21 | 35.40 | 38.23 | 41.42 | 44.80 | 47.87 | 50.99 | 55.10 | 60.55 | 65.00 |
| Gastrointestinal Diseases | 34.01 | 36.37 | 40.04 | 42.84 | 45.71 | 49.59 | 53.20 | 58.63 | 64.27 | 70.56 | 76.58 |
| Infectious Diseases | 50.60 | 55.27 | 59.99 | 65.37 | 70.73 | 76.63 | 83.24 | 91.12 | 99.57 | 107.79 | 115.15 |
| Diabetes | 41.90 | 45.58 | 49.92 | 54.70 | 60.32 | 66.01 | 72.74 | 79.20 | 86.50 | 93.70 | 100.43 |
| Others | 33.61 | 36.57 | 40.19 | 43.90 | 48.24 | 53.15 | 58.40 | 64.26 | 69.40 | 74.89 | 81.91 |
Generic Pharmaceuticals Market Size By Product 2024 to 2034 (USD )
| Product | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Small Molecule | 320.45 | 348.17 | 376.71 | 408.42 | 442.19 | 480.64 | 519.89 | 560.89 | 610.73 | 657.95 | 716.16 |
| Large Molecule | 104.53 | 112.30 | 122.20 | 132.15 | 143.52 | 153.98 | 167.72 | 184.14 | 196.51 | 216.69 | 231.51 |
Generic Pharmaceuticals Market Size By Route of Administration 2024 to 2034 (USD )
| Route of Administration | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oral | 233.01 | 251.94 | 270.09 | 292.56 | 318.12 | 346.63 | 375.90 | 405.79 | 437.70 | 475.12 | 513.61 |
| Injectable | 127.99 | 137.82 | 151.81 | 164.07 | 178.32 | 192.69 | 207.40 | 224.99 | 245.85 | 267.23 | 292.12 |
| Inhalable | 42.28 | 46.74 | 51.26 | 55.88 | 59.45 | 62.99 | 69.75 | 77.07 | 83.14 | 88.41 | 94.04 |
| Others | 21.71 | 23.96 | 25.76 | 28.08 | 29.82 | 32.31 | 34.56 | 37.18 | 40.55 | 43.88 | 47.90 |
Generic Pharmaceuticals Market Size By Distribution Channel 2024 to 2034 (USD )
| Distribution Channel | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Retail Pharmacies | 211.92 | 228.54 | 247.68 | 268.79 | 291.56 | 315.04 | 341.16 | 373.89 | 401.67 | 433.94 | 474.18 |
| Online Pharmacies | 83.99 | 91.01 | 98.88 | 107.33 | 113.99 | 126.23 | 135.87 | 145.79 | 159.82 | 170.54 | 182.60 |
| Hospital Pharmacies | 129.07 | 140.92 | 152.35 | 164.45 | 180.17 | 193.35 | 210.57 | 225.35 | 245.75 | 270.16 | 290.89 |
Generic Pharmaceuticals Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 173.21 | 186.81 | 200.09 | 216.58 | 233.53 | 252.19 | 268.95 | 288.94 | 316.47 | 342.05 | 371.20 |
| Asia Pacific | 104.94 | 114.88 | 126.29 | 138.91 | 151.72 | 165.74 | 181.10 | 200.06 | 217.10 | 234.80 | 255.08 |
| Europe | 91.85 | 99.80 | 107.11 | 114.32 | 124.68 | 134.61 | 147.77 | 158.54 | 170.16 | 185.68 | 201.36 |
| Latin America | 29.76 | 31.99 | 35.49 | 38.60 | 41.04 | 43.94 | 48.21 | 52.53 | 55.88 | 60.28 | 65.41 |
| Middle East and Africa | 25.22 | 26.99 | 29.94 | 32.17 | 34.76 | 38.14 | 41.59 | 44.95 | 47.63 | 51.84 | 54.63 |
Generic Pharmaceuticals Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
